AgentClinical — Clinical trials intelligence
Server Details
ClinicalTrials.gov intelligence — search 400K+ trials by condition, intervention, sponsor, or phase. Get full trial details, eligibility criteria, and aggregate stats.
- Status
- Healthy
- Last Tested
- Transport
- Streamable HTTP
- URL
Glama MCP Gateway
Connect through Glama MCP Gateway for full control over tool access and complete visibility into every call.
Full call logging
Every tool call is logged with complete inputs and outputs, so you can debug issues and audit what your agents are doing.
Tool access control
Enable or disable individual tools per connector, so you decide what your agents can and cannot do.
Managed credentials
Glama handles OAuth flows, token storage, and automatic rotation, so credentials never expire on your clients.
Usage analytics
See which tools your agents call, how often, and when, so you can understand usage patterns and catch anomalies.
Tool Definition Quality
Average 4/5 across 3 of 3 tools scored.
Each tool has a clearly distinct purpose: search for trials, get detailed information on a specific trial, and get aggregate statistics. No overlapping functionality exists.
All tool names follow a consistent verb_noun pattern: get_trial_details, get_trial_stats, search_trials. The naming is predictable and uniform.
Three tools is well-scoped for a clinical trials intelligence server, covering the primary needs of search, detail lookup, and statistical overview without unnecessary bloat.
The core workflow of searching, retrieving details, and understanding trends is covered. Minor gaps include lack of location-based search or direct trial comparison, but these are not critical for the stated purpose.
Available Tools
3 toolsget_trial_detailsAInspect
Get full details of a specific clinical trial by NCT ID. Returns title, summary, description, eligibility criteria, primary/secondary outcomes, sponsor, collaborators, locations, and results summary if available.
| Name | Required | Description | Default |
|---|---|---|---|
| nct_id | Yes | ClinicalTrials.gov NCT ID (e.g. "NCT03232697") |
Tool Definition Quality
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
With no annotations provided, the description carries the burden of behavioral disclosure. It details what the tool returns, including optional fields ('results summary if available'), and describes a read-only operation. It does not mention error handling, permissions, or rate limits, but for a simple retrieval tool this is sufficient.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is a single, well-structured sentence that front-loads the purpose and then lists the return fields efficiently. Every phrase adds value without redundancy.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
For a simple one-parameter tool with no output schema, the description thoroughly covers what the tool does and what it returns. It provides enough context for an agent to select and invoke it correctly, including the optional results caveat.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema coverage is 100%: the nct_id parameter is well-described with an example. The tool description adds no additional meaning beyond restating 'by NCT ID,' so it does not go beyond the schema.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description begins with a specific verb and resource: 'Get full details of a specific clinical trial by NCT ID.' It enumerates the exact return contents (title, summary, criteria, outcomes, etc.), clearly distinguishing it from sibling tools like search_trials (searching) and get_trial_stats (statistical summaries).
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description implies the tool is for fetching complete details when you already have an NCT ID, which differentiates it from search_trials. However, it does not explicitly state when not to use it or mention alternative tools, so it lacks explicit exclusions.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
get_trial_statsAInspect
Get clinical trial statistics and trends for a condition. Returns counts by status (recruiting, completed, etc.), by phase, and top sponsors. Useful for: "How many Alzheimer's trials are recruiting right now?"
| Name | Required | Description | Default |
|---|---|---|---|
| group_by | No | Grouping dimension: status (default), phase, or sponsor | status |
| condition | Yes | Disease or condition to analyze (e.g. "alzheimer", "lung cancer", "covid") |
Tool Definition Quality
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
With no annotations, the description carries the burden. It discloses the output categories (status, phase, top sponsors) but does not state whether the operation is read-only (implied by 'get'), whether condition matching is exact or partial, or what happens when no data matches. The word 'trends' is somewhat ambiguous since the described outputs are counts, not time-based trends, which introduces slight inconsistency.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is compact and front-loaded: a one-sentence purpose, a one-sentence output explanation, and a practical example. No filler or redundancy; every sentence earns its place.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
Given the tool's relative simplicity, two parameters, and no output schema, the description covers the key aspects: what the tool returns (counts by status/phase/sponsor) and a representative usage scenario. It could be more complete by explicitly stating the output is aggregate statistics only (not individual trial data) and that it is a read-only operation, but the core information is present.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
The input schema already provides full descriptions for both parameters (condition and group_by) with 100% coverage. The description adds a few example values for condition and mentions the grouping dimensions (status, phase, sponsor) but does not significantly extend beyond the schema's own parameter documentation, so the baseline of 3 is appropriate.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description opens with a specific verb+resource: 'Get clinical trial statistics and trends for a condition.' It clearly distinguishes from siblings (search_trials, get_trial_details) by focusing on aggregate counts and trends rather than individual trial search or details. The example question further clarifies the tool's purpose.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description provides a concrete use-case example ('How many Alzheimer's trials are recruiting right now?') that signals when to use the tool for aggregate statistical questions. However, it does not explicitly mention when not to use it (e.g., for individual trial details) or directly reference alternatives, so it stops short of full exclusion guidance.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
search_trialsAInspect
Search clinical trials on ClinicalTrials.gov by condition, intervention, sponsor, status, or phase. Returns trial IDs, titles, status, phases, conditions, interventions, enrollment, and locations count.
| Name | Required | Description | Default |
|---|---|---|---|
| limit | No | Number of results (max 20) | |
| phase | No | Trial phase: PHASE1, PHASE2, PHASE3, PHASE4 | |
| status | No | Trial status: RECRUITING, COMPLETED, ACTIVE_NOT_RECRUITING, NOT_YET_RECRUITING, TERMINATED | |
| sponsor | No | Sponsor name (e.g. "Pfizer", "NIH", "Mayo Clinic") | |
| condition | No | Disease or condition (e.g. "diabetes", "breast cancer", "alzheimer") | |
| intervention | No | Drug, device, or intervention (e.g. "metformin", "pembrolizumab") |
Tool Definition Quality
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
No annotations are provided, so the description carries the full burden of behavioral disclosure. It mentions return fields and search criteria but does not disclose whether the operation is read-only, any authentication requirements, error handling, or behavior for empty results. For a search tool, the description adds limited behavioral context beyond the obvious read-only nature implied by 'search'.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is concise and front-loaded, stating the primary action and resource in the first sentence, followed by a clear list of returned fields. Every sentence adds value with no redundant or extraneous content.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
The description adequately covers the tool's purpose and return fields, which is important given no output schema. It does not mention sorting, pagination, or how the limit parameter affects results, but those details are captured in the schema. For a search tool with six optional parameters, the description is reasonably complete, though it could mention when to use sibling tools.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100%, so the parameters are already well-documented in the schema. The description lists the search dimensions (condition, intervention, sponsor, status, phase) which map to parameters, but it does not add new semantic meaning beyond the schema. Examples like 'Pfizer' and 'metformin' provide minor illustrative value but do not significantly enhance understanding.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description uses a specific verb ('Search') and identifies the exact resource ('clinical trials on ClinicalTrials.gov') and the search criteria (condition, intervention, sponsor, status, phase). It clearly distinguishes from sibling tools like get_trial_details and get_trial_stats, which focus on specific trial info and statistics rather than discovery.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description implies the tool is for searching trials by various criteria, providing enough context for when to use it. However, it does not explicitly mention alternatives or conditions when this tool should not be used, such as pointing to get_trial_details for detailed trial information. No exclusions or alternative recommendations are given.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
Claim this connector by publishing a /.well-known/glama.json file on your server's domain with the following structure:
{
"$schema": "https://glama.ai/mcp/schemas/connector.json",
"maintainers": [{ "email": "your-email@example.com" }]
}The email address must match the email associated with your Glama account. Once published, Glama will automatically detect and verify the file within a few minutes.
Control your server's listing on Glama, including description and metadata
Access analytics and receive server usage reports
Get monitoring and health status updates for your server
Feature your server to boost visibility and reach more users
For users:
Full audit trail – every tool call is logged with inputs and outputs for compliance and debugging
Granular tool control – enable or disable individual tools per connector to limit what your AI agents can do
Centralized credential management – store and rotate API keys and OAuth tokens in one place
Change alerts – get notified when a connector changes its schema, adds or removes tools, or updates tool definitions, so nothing breaks silently
For server owners:
Proven adoption – public usage metrics on your listing show real-world traction and build trust with prospective users
Tool-level analytics – see which tools are being used most, helping you prioritize development and documentation
Direct user feedback – users can report issues and suggest improvements through the listing, giving you a channel you would not have otherwise
The connector status is unhealthy when Glama is unable to successfully connect to the server. This can happen for several reasons:
The server is experiencing an outage
The URL of the server is wrong
Credentials required to access the server are missing or invalid
If you are the owner of this MCP connector and would like to make modifications to the listing, including providing test credentials for accessing the server, please contact support@glama.ai.
Discussions
No comments yet. Be the first to start the discussion!
Related MCP Servers
- AlicenseAqualityAmaintenanceGTM signal intelligence suite for AI agents. Six tools: hiring signals, tech stack detection, company-to-LinkedIn resolution, ICP scoring, job board scanning, and a combined signals aggregator. Built for outbound sales workflows.111111MIT

industrylens-mcpofficial
Flicense-qualityCmaintenanceBrowse IndustryLens's published competitive-intelligence reports and head-to-head competitor comparisons from any AI agent — real, source-backed data.
Sociality MCPofficial
Alicense-qualityDmaintenanceSocial media analytics, post insights, and competitor benchmarking for AI agents.6MIT- AlicenseAqualityAmaintenanceDetects hiring intent signals by scanning job boards for specific companies. Returns structured role data for outbound sales targeting.1901MIT